Gout drug could reduce Covid hospital stays, new research finds

Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings

A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.

The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *